Aflibercept versus placebo in combination with FOLFIRI in previously treated metastatic colorectal cancer (mCRC): Mean overall survival (OS) estimation from a phase III trial (VELOUR).
- 20 May 2012
- journal article
- meeting report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (15_suppl), 3602
- https://doi.org/10.1200/jco.2012.30.15_suppl.3602